Skip to content

Cross-cultural translation and reliability and validity testing of the Myasthenia Gravis Impairment Index (MGII): a multi-center, cross-sectional study

Cross-cultural translation and reliability and validity testing of the Myasthenia Gravis Impairment Index (MGII): a multi-center, cross-sectional study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043291
Enrollment
Unknown
Registered
2021-02-09
Start date
2021-02-15
Completion date
Unknown
Last updated
2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myasthenia gravis

Interventions

Myasthenia Gravis Case Group:Nil

Sponsors

Department of Neurology, The Second Affiliated Hospital of Air Force Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who have been diagnosed with myasthenia gravis (MG) as assessed by the neurologists of our center or other top-tier hospitals and meet the diagnostic criteria of the 2015 Chinese Myasthenia Gravis Guidelines; 2. Aged 18-80 years, with normal cognitive function, can understand and cooperate to complete the scale test; 3. The symptoms and drug regimen are stable for more than 1 month; 4. The subject voluntarily joined the study and signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with serious underlying diseases, such as liver and kidney failure, heart failure, etc., which may affect the correct score of the scale; 2. Patients suffering from mental illness or severe emotional disorder, which affects the score evaluation.

Design outcomes

Primary

MeasureTime frame
MGII scale score;QMG scale score;MG-ADL scale score;

Secondary

MeasureTime frame
QoL-15 scale score;MGC scale score;

Countries

China

Contacts

Public ContactChang Ting

The Second Affiliated Hospital of Air Force Medical University

changting1981@163.com+86 29-84778845

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026